你即將離開本站

並前往https://seekingalpha.com/news/3707545-orphazyme-gets-fda-thumbs-down-for-arimoclomol-cuts-fy21-outlook

Orphazyme (ORPH) stock slumps on FDA thumbs down for ...

Orphazyme (NASDAQ:ORPH) has received a Complete Response Letter (CRL) from the FDA following its review of the new drug application (NDA) ...

確定！ 回上一頁

查詢 「ORPH FDA」的人也找了：

  1. ORPH FDA approval
    2.
  2. Orphazyme A/S news
    3.
  3. Orphazyme
    4.
  4. FDA IND database
    5.
  5. Orphan drug Act
    6.
  6. ORPH stock
    7.
  7. Orphan FDA
    8.
  8. Orphazyme as adr
    9.